Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study.

导出 OA

翻译打印收藏纠错

作者： Baptiste,Maille ^[1] ; Marie,Wilkin ^[1] ; Matthieu,Million ^[2] ; Noémie,Rességuier ^[3] ; Frédéric,Franceschi ^[1] ; Linda,Koutbi-Franceschi ^[1] ; Jérôme,Hourdain ^[1] ; Elisa,Martinez ^[1] ; Maxime,Zabern ^[1] ; Christophe,Gardella ^[4] ; Hervé,Tissot-Dupont ^[2] ; Jagmeet P,Singh ^[5] ; Jean-Claude,Deharo ^[6] ; Laurent,Fiorina ^[7]

作者单位： Assistance Publique - Hôpitaux de Marseille, Centre Hospitalier Universitaire La Timone, Service de Cardiologie, Marseille, France; Aix Marseille University, C2VN, Marseille, France. ^[1] IHU-Méditerranée Infection, Marseille, France; Aix-Marseille University, IRD, APHM, MEPHI, Marseille, France. ^[2] Department of Epidemiology and Health Economics, APHM, Marseille, France. ^[3] Cardiologs Technologies, Paris, France. ^[4] Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. ^[5] Assistance Publique - Hôpitaux de Marseille, Centre Hospitalier Universitaire La Timone, Service de Cardiologie, Marseille, France; Aix Marseille University, C2VN, Marseille, France. Electronic address: jean-claude.deharo@ap-hm.fr. ^[6] Institut Cardiovasculaire Paris-Sud, Hôpital Privé Jacques Cartier, Ramsay, Massy, France. ^[7]

关键词 Artificial intelligence COVID-19 Hydroxychloroquine-azythromycine QTc interval Smartwatch